2-{2-{(2-hydroxyethyl)amino}ethyl}-5-{{2-methylamino)ethyl}amino}indazolo{4,3-gh}isoquinolin-6(2h)-one as antitumor agent

摘要

PCT No. PCT/EP96/03935 Sec. 371 Date Jun. 22, 1998 Sec. 102(e) Date Jun. 22, 1998 PCT Filed Sep. 9, 1996 PCT Pub. No. WO97/10245 PCT Pub. Date Mar. 20, 1997The present invention relates to 2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-methylamino)ethyl]amino]indazolo[4,3-gh]isoquinolin-6(2H)-one and the pharmaceutically acceptable acid addition salts thereof, of formula (I). This compound has shown a high a antitumor activity.